In sickness and in health: Living HIV positive kidney donation from a wife to her husband, with 7 years' post-transplant follow-up.


Journal

Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 05 06 2019
revised: 04 08 2019
accepted: 01 09 2019
pubmed: 14 9 2019
medline: 1 5 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Human immunodeficiency virus (HIV) infection was traditionally considered an absolute contraindication for kidney transplantation. After the introduction of ART, several studies have demonstrated comparable patient and graft outcomes between HIV-negative and HIV-positive kidney recipients. The US Congress passed the HIV Organ Policy Equity (HOPE) Act in 2013, which permits research in the area of HIV-positive to HIV-positive transplantation. HIV-infected living donation is also permitted under the HOPE Act. However, there is a concern regarding the safety of kidney donation in an HIV-infected person, given the risk of renal disease associated with HIV infection. We report here the case of successful kidney transplantation from HIV-positive living donor to HIV-positive recipient performed in our center on July 2012. To the best of our knowledge, this is the earliest case done in this medical context to be reported in the literature, therefore, potentially carrying several important messages to the transplantation community. In the present case, the living-donor kidney transplant was performed between a married couple infected with same strain of HIV-1, both on effective ART with efficiently suppressed viral replication and satisfactory pre-transplantation immune status.

Identifiants

pubmed: 31518477
doi: 10.1111/tid.13171
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13171

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Suthanthiran M, Storm TB. Renal transplantation. N Engl J Med. 1994;331:365-376.
Spital A. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? Transplantation. 1998;65(9):1187-1191.
Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384:241-248.
Blumberg EA, Rogers CC. American society of transplantation infectious diseases community of practice. Solid organ transplantation in the HIV-infected patient: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;17:e13499.
Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363:2004-2014.
Roland ME, Barin B, Huprikar S, et al. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS. 2016;30:435-444.
Locke JE, Gustafson S, Mehta S, et al. Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg. 2017;265:604-608.
Cohen JB, Locke JE, Shelton BS, et al. Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus. Clin Transplant. 2019;33:e13466.
Muller E, Barday Z, Mendelson M, et al. HIV-positive-to-HIV-positive kidney transplantation-results at 3 to 5 years. N Engl J Med. 2015;372:613-620.
Organ procurement and transplantation: implementation of the HIV organ policy equity act. http://www.federalregister.gov/articles/2015/05/08/2015-11048/organ-procurement-andtransplantation-implementation-of-the-hiv-organ-policy-equity-act. Accessed September 17, 2015.
Malani P. HIV and transplantation: new reasons for HOPE. JAMA. 2016;316:136-138.
Ryom L, Mocroft A, Kirk O, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A: D study. J Infect Dis. 2013;207:1359-1369.
Abraham AG, Althoff KN, Jing Y, et al. End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015;60:941-949.
Lentine KL, Kasiske BL, Levey LS, et al. Summary of kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors. Transplantation. 2017;101:1783-1792.
Muzaale AD, Althoff KN, Sperati CJ, et al. Risk of end stage renal disease in HIV-positive potential live kidney donors. Am J Transplant. 2017;17:1823-1832.
Avidor B, Turner D, Mor Z, et al. Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behaviour trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy. PLoS ONE. 2013;8:e57789.
https://blast.ncbi.nlm.nih.gov/Blastcgi. Accessed August 3, 2019.
Boyarsky BJ, Hall EC, Singer AL, et al. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant. 2011;11:1209-1217.
Sanchez OA, Ferrara LK, Rein S, et al. Hypertension after kidney donation: incidence, predictors, and correlates. Am J Transplant. 2018;18:2534-2543.
Touzot M, Pillebout E, Matignon M, et al. Renal transplantation in HIV-infected patients: the Paris experience. Am J Transplant. 2010;10:2263-2269.
Degnan KO, Blumberg EA. Human Immunodeficiency virus in kidney transplantation. Semin Nephrol. 2016;36:405-416.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.

Auteurs

Ayelet Grupper (A)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yaacov Goykhman (Y)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Roni Baruch (R)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dan Turner (D)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Infectious Diseases Department, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Daniel Elbirt (D)

Clinical Immunology, Allergy and Neve-Or AIDS Center, Kaplan Medical Center, Rehovot, Israel.

Lily Okrent Smolar (L)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Polina Katz (P)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Ido Nachmany (I)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nir Lubezky (N)

Organ Transplantation Unit, The Surgical Division, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eugene Katchman (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Infectious Diseases Department, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH